Developing, funding and conducting clinical trials in immune tolerance
LITTMUS: Liver Transplantation with Tregs at MGH and UCSF
A clinical trial for liver transplant candidates
Not yet enrolling study participants
The LITTMUS study maybe an option for you.
If you are 18+ and are a liver transplant candidate, you may be eligible to participate in LITTMUS.
Learn more ›
LITTMUS is two separate studies. One study is being conducted at MGH in Boston, MA and the other at UCSF in San Francisco, CA.
A clinical study testing a new approach using T regulatory cells to possibly stop anti-rejection medications after liver transplantation.